14% of Nigeria's population use Cannabis, Codeine, and other hard drugs

Cannabis, popularly known as Marijuana in Nigeria was the most widely used substance in Nigeria, followed by tramadol, codeine or morphine and cough syrups containing codeine or dextromethorphan

Tramadol and codeine are some of the substances that have taken the attention of youths in Nigeria
  • 14% of the country's population between the age of 15 and 64 in Nigeria use hard drugs.
  • The report also states that those with a high risk of drug users account for 0.4% of the population, about 376,000 people.
  • NBS says the project aims to support Nigeria in fighting drug production, trafficking and use and improved access to quality drug prevention, treatment and care services.

In Nigeria, 14.3 million people of the total population made use of the various form of hard drugs, excluding alcohol and tobacco-related products.

This figure represents 14% of the country's population between the age of 15 and 64 in the year 2017.

This was revealed by National Bureau of Statistics (NBS) in its report, Drug Use in Nigeria 2018 Survey released on Tuesday, January 30, 2019.

The report, the first in Nigeria was conducted in collaboration with the Centre for Research and Information on Substance Abuse (CRISA) with technical support from the United Nations Office on Drugs and Crime (UNODC). It was funded by the European Union (EU) under the 10th European Development Fund (EDF)

Titled, “Response to Drugs and Related Organised Crime in Nigeria,” the report estimates people who had used a drug at least once in the past 12 months as well as high-risk drug users.

NBS says the project aims to support Nigeria in fighting drug production, trafficking and use and improved access to quality drug prevention, treatment and care services.

According to the NBS report, Cannabis, popularly known as Marijuana in Nigeria, “was the most widely used substance in the past year in Nigeria, followed by pharmaceutical opioids (mainly tramadol, and to lesser extent codeine or morphine) and cough syrups containing codeine or dextromethorphan.

The report also states that those with a high risk of drug users account for 0.4% of the population, about 376,000 people.

Here is the extent of drug use in Nigeria

  • Any drug use - 14,300,000
  • Cannabis - 10,640,000
  • Opiods - 4,610,000
  • Heroin - 87,000
  • Pharmaceutical Opioids (Tramadol. Codeine, Morphine) - 4,608,000
  • Cocaine - 92,000
  • Tranquillisers/Sedatives - 481,000
  • Cough Syrups - 2,360,000

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.

Eyewitness? Submit your stories now via social or:

Email: news@pulselive.co.ke

Recommended articles

LIVE: Results from Kenya's 2022 elections

LIVE: Results from Kenya's 2022 elections

Africa’s richest man Aliko Dangote poised to overtake another Russian billionaire Vladimir Lisin on Bloomberg billionaires list

Africa’s richest man Aliko Dangote poised to overtake another Russian billionaire Vladimir Lisin on Bloomberg billionaires list

Mzee Kibor's will made public, revealing how vast wealth and millions will be distributed

Mzee Kibor's will made public, revealing how vast wealth and millions will be distributed

Ini Edo posts new photos amid reports of welcoming a baby through surrogacy

Ini Edo posts new photos amid reports of welcoming a baby through surrogacy

Machakos billionaire buys 680 Hotel in Nairobi

Machakos billionaire buys 680 Hotel in Nairobi

Referee behind chaos at AFCON was rushed to hospital after match

Referee behind chaos at AFCON was rushed to hospital after match

Ne-Yo speaks out after wife Crystal announced end of their 8-year marriage

Ne-Yo speaks out after wife Crystal announced end of their 8-year marriage

Eddie Butita speaks on his fallout with Miss Mandi, offers her a job

Eddie Butita speaks on his fallout with Miss Mandi, offers her a job

Africa's richest man, Aliko Dangote, adds extra $915 million to his vast wealth in Q1 2022

Africa's richest man, Aliko Dangote, adds extra $915 million to his vast wealth in Q1 2022